Vasily Fedorin

Director de Operaciones en

4BIO Ventures Management Ltd.

Distribution Services

Consumer Services

Finance

Perfil

Vasily Fedorin is currently the Chief Operating Officer at 4BIO Ventures Management Ltd. He previously worked as a Marketing Manager at MS WESTFALIA GmbH from 2009 to 2010.
Dr. Fedorin holds a doctorate degree from Lomonosov Moscow State University Business School, which was conferred in 2008.

Cargos activos de Vasily Fedorin

Empresas	Cargo	Inicio
4BIO Ventures Management Ltd. 4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements.	Director de Operaciones	01/03/2022

Todos los cargos activos de Vasily Fedorin

Antiguos cargos conocidos de Vasily Fedorin.

Empresas	Cargo	Fin
MS WESTFALIA GmbH MS WESTFALIA GmbH Medical DistributorsDistribution Services Distributes medical equipment	Inversor de Capital Privado	01/02/2010

Ver el detalle de la experiencia de Vasily Fedorin.

Formación de Vasily Fedorin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Vasily Fedorin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
MS WESTFALIA GmbH MS WESTFALIA GmbH Medical DistributorsDistribution Services Distributes medical equipment	Distribution Services
Lomonosov Moscow State University Business School Lomonosov Moscow State University Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
4BIO Ventures Management Ltd. 4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements.	Finance